← FDA Drug Approvals (Drugs@FDA)
IMATINIB MESYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2020-07-23
Drug application
- FDA Application #
ANDA212773- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IMATINIB MESYLATE
- Generic name
- IMATINIB MESYLATE
- Active ingredients
- IMATINIB MESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- EUGIA PHARMA
- Manufacturer
- BluePoint Laboratories
- First approval
- 2020-07-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown